Pharmacology Books
CRC Press Handbook of Systemic Drug Treatment in
Book SynopsisThe Handbook of Systemic Drug Treatment in Dermatology helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. Written for dermatologists, family practitioners, pharmacists and specialist nurses, this completely revised and updated third edition of a bestseller provides an accessible and concise aid to prescribing and monitoring systemic dermatologic therapy. For each drug or drug class, the book lists its classification, mode of action, formulations, dosages, suggested regimens, contraindications, important drug interactions, adverse effects, patient information, and more. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.FROM REVIEWS OF PREVIOUS EDITIONSThis updated edition includes new arrivalsâ Quite simply, it is indispensable! I have it with me in every clinic and oftTable of Contents1. Acitretin. 2. Acne Antibiotics. 3. Alitretinoin 4. Antiandrogens. 5. Antibiotics Commonly Used for Skin Infections. 6. Antifungals. 7. Antimalarials. 8. Antivirals. 9. Apremilast. 10. Azathioprine. 11. Azole Antihelminths. 12. Bexarotene. 13. Ciclosporin. 14. Colchicine. 15. Corticosteroids. 16. Cyclophosphamide. 17. Dapsone. 18. Dimethyl Fumarate. 19. Interleukin 4/13 inhibitors. 20. Interleukin (IL)-12/23 and IL-23 Inhibitors. 21. Interleukin-17. antagonists. 22. Isotretinoin. 23. Ivermectin. 24. Intravenous Immunoglobulin. 25. Janus Kinase (JAK) Inhibitors. 26. Malignant Melanoma Drug Treatments. 27. Methotrexate. 28. Mycophenolate Mofetil. 29. Omalizumab. 30. Potassium Iodide. 31. Propranolol. 32. Psoralens. 33. Rituximab. 34. Sulfapyridine & Sulfamethoxy- pyridazine. 35. Thalidomide. 36. Tumour Necrosis Factor Antagonists. 37. Vismodegib. 38. Systemic Treatment in Children. 39. Kidney Disease. 40. Systemic Therapy & Liver Disease. 41. Systematic Therapy in Older People.
£65.54
John Wiley and Sons Ltd Molecular Pharmacology
Book SynopsisProvides an introduction to the rapidly expanding field of molecular pharmacology. Adopting a drug target-based, rather than the traditional organ/system based approach, this book reflects the advances and research trend towards molecular based drug design, derived from a detailed understanding of chemical responses in the body.Trade Review“Overall, it could be the basis of an excellent course for junior pharmacologists in basic science research who need a greater focus on the mechanisms of drug action rather than an encyclopedic survey of clinical drug use.” (Doody’s, 26 July 2013)Table of ContentsPreface ix Abbreviations x 1 Introduction to Drug Targets and Molecular Pharmacology 1 1.1 Introduction to molecular pharmacology 1 1.2 Scope of this textbook 2 1.3 The nature of drug targets 3 1.4 Future drug targets 7 1.5 Molecular pharmacology and drug discovery 11 References 12 2 Molecular Cloning of Drug Targets 13 2.1 Introduction to molecular cloning – from DNA to drug discovery 13 2.2 ‘Traditional’ pharmacology 14 2.3 The relevance of recombinant DNA technology to pharmacology/drug discovery 14 2.4 The ‘cloning’ of drug targets 15 2.5 What information can DNA cloning provide? 20 2.6 Comparing the pharmacologic profile of the ‘cloned’ and the ‘native’ drug target 23 2.7 Reverse pharmacology illustrated on orphan GPCRs 24 2.8 Summary 27 References 27 3 G Protein-coupled Receptors 31 3.1 Introduction to G protein-coupled receptors 31 3.2 Heterotrimeric G-proteins 36 3.3 Signal transduction pathways 40 3.4 Desensitisation and down-regulation of GPCR signalling 44 3.5 Constitutive GPCR activity 45 3.6 Promiscuous G-protein coupling 47 3.7 Agonist-directed signalling 48 3.8 Allosteric modulators of GPCR function 49 3.9 Pharmacological chaperones for GPCRs 50 3.10 GPCR dimerisation 51 3.11 GPCR splice variants 63 3.12 Summary 67 References 67 Useful Web sites 70 4 Ion Channels 71 4.1 Introduction 71 4.2 Voltage-gated ion channels 73 4.3 Other types of voltage-gated ion channels 89 4.4 Ligand-gated ion channels 109 4.5 Summary 125 References 125 5 Transporter Proteins 129 5.1 Introduction 129 5.2 Classification 129 5.3 Structural analysis of transporters 132 5.4 Transporter families of pharmacological interest 133 5.5 Transporters and cellular homeostasis 167 5.6 Summary 169 References 169 6 Cystic Fibrosis: Alternative Approaches to the Treatment of a Genetic Disease 175 6.1 Introduction 175 6.2 Cystic fibrosis transmembrane conductance regulator 179 6.3 Mutations in CFTR 183 6.4 Why is cystic fibrosis so common? 184 6.5 Animal models of Cystic fibrosis 186 6.6 Pharmacotherapy 186 6.7 Gene therapy 191 6.8 Conclusion 195 References 196 7 Pharmacogenomics 201 7.1 Types of genetic variation in the human genome 201 7.2 Thiopurine S-methyltransferase and K+ channel polymorphisms 202 7.3 Polymorphisms affecting drug metabolism 204 7.4 Methods for detecting genetic polymorphisms 209 7.5 Genetic variation in drug transporters 211 7.6 Genetic variation in G protein coupled receptors 215 7.7 Summary 225 References 225 Useful Web sites 226 8 Transcription Factors and Gene Expression 227 8.1 Control of gene expression 227 8.2 Transcription factors 229 8.3 CREB 233 8.4 Nuclear receptors 238 8.5 Peroxisome proliferator-activated receptors 240 8.6 Growth factors 247 8.7 Alternative splicing 247 8.8 RNA editing 251 8.9 The importance of non-coding RNAs in gene expression 257 8.10 Summary 270 References 271 9 Cellular Calcium 277 9.1 Introduction 277 9.2 Measurement of calcium 278 9.3 The exocrine pancreas 289 9.4 Calcium signalling in pancreatic acinar cells 292 9.5 Nuclear calcium signalling 303 9.6 Conclusions 310 References 311 10 Genetic Engineering of Mice 315 10.1 Introduction to genetic engineering 315 10.2 Genomics and the accumulation of sequence data 315 10.3 The mouse as a model organism 318 10.4 Techniques for genetic engineering 319 10.5 Examples of genetically-engineered mice 332 10.6 Summary 334 References 334 11 Signalling Complexes: Protein-protein Interactions and Lipid Rafts 339 11.1 Introduction to cell signalling complexes 339 11.2 Introduction to GPCR interacting proteins 340 11.3 Methods used to identify GPCR interacting proteins 340 11.4 Functional roles of GPCR interacting proteins 345 11.5 GPCR signalling complexes 348 11.6 GPCR and ion channel complexes 355 11.7 Ion channel signalling complexes 356 11.8 Development of pharmaceuticals that target GPCR interacting proteins 356 11.9 Development of pharmaceuticals that target protein-protein interactions 356 11.10 Lipid rafts 357 11.11 Receptor-mediated endocytosis 361 11.12 Summary 364 References 364 12 Recombinant Proteins and Immunotherapeutics 367 12.1 Introduction to immunotherapeutics 367 12.2 Historical background of immunotherapeutics 368 12.3 Basis of immunotherapeutics 368 12.4 Types of immunotherapeutics 369 12.5 Humanisation of antibody therapy 372 12.6 Immunotherapeutics in clinical practice 376 12.7 Advantages and disadvantages of immunotherapy 378 12.8 The future 379 12.9 Summary 380 References 380 Glossary 381 Index 403
£53.15
John Wiley & Sons Inc Medicinal Natural Products
Book SynopsisMedicinal Natural Products: A Biosynthetic Approach, Third Edition, provides a comprehensive and balanced introduction to natural products from a biosynthetic perspective, focussing on the metabolic sequences leading to various classes of natural products.Trade Review"Students should be empowered for a deductive analysis of the presented substances." (Arzneimittelforschung, December 2009) "This new edition is an excellent text that is unrivaled in both its scope and overall coverage of natural products biosynthesis." (Journal of Medicinal Chemistry, August 2009) "There is no question that this is the best book available on the biosynthesis and bio-organic chemistry of medicinally important natural products." (Education in Chemistry, September 2009)Table of Contents1 About this book, and how to use it 1 The subject 1 The aim 1 The approach 2 The topics 2 The figures 2 Further reading 3 What to study 3 What to learn 3 Nomenclature 3 Conventions regarding acids, bases, and ions 4 Some common abbreviations 4 Further reading 5 2 Secondary metabolism: the building blocks and construction mechanisms 7 Primary and secondary metabolism 7 The building blocks 8 The construction mechanisms 11 Alkylation reactions: nucleophilic substitution 12 Alkylation reactions: electrophilic addition 12 Wagner–Meerwein rearrangements 15 Aldol and Claisen reactions 15 Imine formation and the Mannich reaction 18 Amino acids and transamination 20 Decarboxylation reactions 22 Oxidation and reduction reactions 24 Dehydrogenases 24 Oxidases 26 Monooxygenases 26 Dioxygenases 26 Amine oxidases 27 Baeyer–Villiger monooxygenases 27 Phenolic oxidative coupling 28 Halogenation reactions 28 Glycosylation reactions 31 Elucidating biosynthetic pathways 34 Further reading 38 3 The acetate pathway: fatty acids and polyketides 39 Fatty acid synthase: saturated fatty acids 39 Unsaturated fatty acids 44 Uncommon fatty acids 53 Prostaglandins 58 Thromboxanes 64 Leukotrienes 64 Polyketide synthases: generalities 66 Polyketide synthases: macrolides 68 Polyketide synthases: linear polyketides and polyethers 90 Diels–Alder cyclizations 96 Polyketide synthases: aromatics 96 Cyclizations 99 Post-polyketide synthase modifications 103 Starter groups 116 Further reading 131 4 The shikimate pathway: aromatic amino acids and phenylpropanoids 137 Aromatic amino acids and simple benzoic acids 137 Phenylpropanoids 148 Cinnamic acids and esters 148 Lignans and lignin 152 Phenylpropenes 156 Benzoic acids from C6C3 compounds 157 Coumarins 161 Aromatic polyketides 166 Styrylpyrones, diarylheptanoids 166 Flavonoids and stilbenes 167 Flavonolignans 173 Isoflavonoids 174 Terpenoid quinones 178 Further reading 184 5 The mevalonate and methylerythritol phosphate pathways: terpenoids and steroids 187 Mevalonic acid and methylerythritol phosphate 188 Hemiterpenes (C5) 192 Monoterpenes (C10) 193 Irregular monoterpenes 204 Iridoids (C10) 206 Sesquiterpenes (C15) 210 Diterpenes (C20) 223 Sesterterpenes (C25) 234 Triterpenes (C30) 234 Triterpenoid saponins 242 Steroids 247 Stereochemistry and nomenclature 247 Cholesterol 248 Phytosterols 251 Vitamin D 256 Steroidal saponins 259 Cardioactive glycosides 265 Bile acids 275 Adrenocortical hormones/corticosteroids 277 Semi-synthesis of corticosteroids 277 Progestogens 287 Oestrogens 290 Androgens 296 Tetraterpenes (C40) 298 Higher terpenoids 306 Further reading 306 6 Alkaloids 311 Alkaloids derived from ornithine 311 Polyamines 311 Pyrrolidine and tropane alkaloids 312 Pyrrolizidine alkaloids 324 Alkaloids derived from lysine 326 Piperidine alkaloids 326 Quinolizidine alkaloids 328 Indolizidine alkaloids 330 Alkaloids derived from nicotinic acid 331 Pyridine alkaloids 331 Alkaloids derived from tyrosine 336 Phenylethylamines and simple tetrahydroisoquinoline alkaloids 336 Modified benzyltetrahydroisoquinoline alkaloids 346 Phenethylisoquinoline alkaloids 359 Terpenoid tetrahydroisoquinoline alkaloids 363 Amaryllidaceae alkaloids 365 Alkaloids derived from tryptophan 366 Simple indole alkaloids 366 Simple β-carboline alkaloids 369 Terpenoid indole alkaloids 369 Quinoline alkaloids 380 Pyrroloindole alkaloids 385 Ergot alkaloids 387 Alkaloids derived from anthranilic acid 395 Quinazoline alkaloids 395 Quinoline and acridine alkaloids 396 Alkaloids derived from histidine 398 Imidazole alkaloids 398 Alkaloids derived by amination reactions 400 Acetate-derived alkaloids 401 Phenylalanine-derived alkaloids 401 Terpenoid alkaloids 406 Steroidal alkaloids 406 Purine alkaloids 413 Caffeine 413 Saxitoxin and tetrodotoxin 416 Further reading 417 7 Peptides, proteins, and other amino acid derivatives 421 Peptides and proteins 421 Ribosomal peptide biosynthesis 422 Peptide hormones 426 Thyroid hormones 426 Hypothalamic hormones 427 Anterior pituitary hormones 429 Posterior pituitary hormones 430 Pancreatic hormones 432 Interferons 433 Opioid peptides 434 Ribosomal peptide toxins 434 Enzymes 438 Non-ribosomal peptide biosynthesis 438 Modified peptides: penicillins, cephalosporins, and other β-lactams 458 Penicillins 458 Cephalosporins 465 Other β-lactams 469 Cyanogenic glycosides 476 Glucosinolates 477 Cysteine sulfoxides 480 Further reading 481 8 Carbohydrates 485 Monosaccharides 485 Oligosaccharides 490 Polysaccharides 493 Aminosugars and aminoglycosides 498 Further reading 507 Index 509
£45.55
Elsevier Health Sciences Medical Pharmacology and Therapeutics
Book SynopsisTable of ContentsPreface Drug Dosage and Nomenclature SECTION 1 GENERAL PRINCIPLES 1. Principles of Pharmacology and Mechanisms of Drug Action 2. Pharmacokinetics 3. Drug Discovery, Safety and Efficacy 4. Neurotransmission and the Peripheral Autonomic Nervous System SECTION 2 THE CARDIOVASCULAR SYSTEM 5. Ischaemic Heart Disease 6. Systemic and Pulmonary Hypertension 7. Heart Failure and Shock 8. Cardiac Arrhythmias 9. Cerebrovascular Disease and Dementia 10. Peripheral Artery Disease 11. Haemostasis SECTION 3 THE RESPIRATORY SYSTEM 12. Asthma and Chronic Obstructive Pulmonary Disease 13. Respiratory Disorders: Cough, Respiratory Stimulants, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis and Neonatal Respiratory Distress Syndrome SECTION 4 THE RENAL SYSTEM 14. Diuretics 15. Disorders of Micturition 16. Erectile Dysfunction SECTION 5 THE NERVOUS SYSTEM 17. General Anaesthetics 18. Local Anaesthetics 19. Opioid Analgesics and the Management of Pain 20. Anxiety, Obsessive-Compulsive Disorder and Insomnia 21. Schizophrenia and Bipolar Disorder 22. Depression, Attention Deficit Hyperactivity Disorder and Narcolepsy 23. Seizures and Epilepsy 24. Extrapyramidal Movement Disorders and Spasticity 25. Other Neurological Disorders: Multiple Sclerosis, Motor Neuron Disease and Guillain-Barré Syndrome 26. Migraine and Other Headaches SECTION 6 THE MUSCULOSKELETAL SYSTEM 27. The Neuromuscular Junction and Neuromuscular Blockade 28. Myasthenia Gravis 29. Nonsteroidal Anti-inflammatory Drugs 30. Rheumatoid Arthritis, Other Inflammatory Arthritides and Osteoarthritis 31. Hyperuricaemia, Gout and Pseudogout SECTION 7 THE GASTROINTESTINAL SYSTEM 32. Nausea and Vomiting 33. Dyspepsia, Peptic Ulcer Disease and Gastrooesophageal Reflux Disease 34. Inflammatory Bowel Disease 35. Constipation, Diarrhoea and Irritable Bowel Syndrome 36. Liver Disease 37. Obesity SECTION 8 THE IMMUNE SYSTEM 38. The Immune Response and Immunosuppressant Drugs 39. Antihistamines and Allergic Disease SECTION 9 THE ENDOCRINE SYSTEM AND METABOLISM 40. Diabetes Mellitus 41. The Thyroid and Control of Metabolic Rate 42. Calcium Metabolism and Metabolic Bone Disease 43. Pituitary and Hypothalamic Hormones 44. Corticosteroids (Glucocorticoids and Mineralocorticoids) 45. Female Reproduction 46. Androgens, Antiandrogens and Anabolic Steroids 47. Anaemia and Haematopoietic Colony-Stimulating Factors 48. Lipid Disorders SECTION 10 THE SKIN AND EYES 49. Skin Disorders 50. The Eye SECTION 11 CHEMOTHERAPY 51. Drugs for Infections 52. Drugs for Cancer SECTION 12 GENERAL FEATURES, TOXICITY AND PRESCRIBING 53. Drug Toxicity and Overdose 54. Substance Abuse and Dependence 55. Prescribing, Adherence and Information About Medicines 56. Drug Therapy in Special Situations Index
£53.19
Elsevier Australia Herbs and Natural Supplements Volume 2
Book Synopsis
£44.57
Taylor & Francis Inc Medicinal Chemistry
Book SynopsisMedicinal Chemistry teaches essential concepts by focusing on how the field is actually practiced, melding real-world research experience with basic principles and modern methods. Written by practicing medicinal chemists, this textbook is intended for advanced undergraduates and first-year graduate students in biology, chemistry, and biochemistry. Pre-medical or pre-pharmacy students and professionals entering the drug discovery field will also find it a useful reference. Building on a foundation of synthetic organic chemistry and structural biology, the book interweaves therapeutics, case studies, historical context, and techniques for discovering, developing, and optimizing new drugs. Chapters are richly illustrated and include problems and annotated journal references with accompanying exercises and answers. Authored by practicing medicinal chemistsâmelding real-world research experience with basic concepts and up-to-date methods Flexible in presentationâ the first five chapters provide a conceptual foundation and historical understanding of the field; subsequent chapters explore the application of concepts. Chapters can be assigned in order of instructor preference and desired emphasis Presents easy-to-follow tables and descriptions of assays next to their relevance to medicinal chemistry and drug discovery, along with target valuesâinformation rarely found all in one place, but is a crucial reference Case studies and Journal Club use current literature to apply concepts from the text to real-life examples. They are also suitable for flipped classrooms and self-study Table of ContentsPART I: Drug Discovery and Development 1. Historical Perspective and Overview of Drug Discovery 2. Drug discovery: Hit and Lead Discovery 3. Drug Discovery: Optimization of Lead Properties PART II: Classes of Drug Targets 4. Medicinal Chemistry Strategies Used in Lead Optimization 5. The Process of Developing a Drug from an Optimized Lead 6. Receptors as Drug Targets 7. Enzymes as Drug Targets 8. Protein-Protein Interactions and Lipids as Drug Targets 9. DNA and RNA as Drug Targets PART III: Selected Therapeutic Areas 10. Anti-Cancer Drugs 11. Infectious Diseases I: Antiviral and Antifungal Drugs 12. Infectious Diseases II: Antibacterial and Antiparasitic Drugs 13. Drugs Acting on the CNS
£105.00
CRC Press Inc Handbook of Stress Medicine and Health
Book SynopsisResearch now shows us that long-term activation of the stress cycle can have a hazardous, even lethal, effect on the body, increasing the risk of obesity, heart disease, depression, cancer, and other illnesses. This new edition of an award-winning book presents cutting-edge research on the effects of stress. Edited by one of the world's authorities in stress management, occupational psychology, and occupational medicine, Handbook of Stress Medicine and Health, Second Edition offers a completely revised and updated look at the different types of stress, including their characteristics, symptoms, duration, and treatment approaches. The text proposes a generic theory on stress and health and explores the relationship of stress to a variety of health outcomes, including heart disease, cancer, mental health, burnout, and complications of the endocrine and immune systems. It addresses the link between stress and personality, and discusses the impact of social support on various heTrade Review“This book states its objective as the further development of the field of ‘stress medicine’ – the multi-disciplinary study of stress by psychologists, medics, occupational health physicians and other related disciplines. … It covers a wide range of topics, including links between stress and health outcomes, the links between stress and personality and organizational and cultural influences on stress and its prevention, and the relationships between stress and a range of health outcomes, including cancer, heart disease, mental health (including anxiety and depression) and disorders of the immune system. … this is an important book that provides an excellent text for students and experienced practitioners alike on the subject of stress medicine. …” — Richard Scaife, The Keil Centre Limited, Edinburgh, UK, in Ergonomics, Vol 50, No. 5, 793-794, May 2007Table of ContentsConceptual Issues in Research on Stress and Health. Stress and Cancer: The Critical Research. Stress and Cancer: The Practice. Stress and Prevention of Cardiovascular Disease. The Role of Stress in Mental Illness: The Practice. Stress, Endocrine Manifestations, and Diseases. Stress, Immunity, and Disease. Stress and Burnout: The Critical Research. Organizational Interventions to Alleviate Burnout and Build Engagement with Work. Hardy Personality, Stress, and Health. Stress, Culture, and Personality. Social Support and Heart Disease. Social Support, Life Events, and Depression in HIV Disease. Interpersonal Communication: The Key to Unlocking Social Support for Preventive Stress Management. Emotional Processing of Traumatic Events. Gender Differences in the Management of Work Stress: Preventing Distress and Savoring Eustress. Dealing with Stress: Families and Chronic Illness. Dealing with Workplace Stress. The Many Faces of Control at Work.
£63.04
Ebury Publishing The Bach Remedies Repertory Supplementary Guide
Book SynopsisThis book looks at the Bach Flower remedies, which are homeopathic treatments for mood and health. This guide helps readers choose and administer the right remedy for their symptoms.
£11.69
Pharmaceutical Press Stockleys Herbal Medicines Interactions
Book SynopsisInvaluable reference text for all healthcare professionals who require evidence-based information on the interactions of conventional medicines with herbal medicines, dietary supplements and nutraceuticals.
£74.25
CRC Press Ethnobotany
Book SynopsisIn this book we present recent studies that have been carried out on some widely used medicinal plants. The need for new and alternative treatments stem from the lack of efficiency of existing remedies for certain illnesses. We have compiled information that may be useful to researchers in their quest to develop new drugs.Table of ContentsPart 1: Ethnobotany 1. The Genus Aloysia Paláu (Verbenaceae) in Argentina. A Paradigm in Ethnobotany 2. Ethnobotany of Medicinal and Sacred Plants with Ethnopharmacological Potential from Southwestern Colombia 3. Ethnobotanical Uses and Potential Pharmaceutical Applications of the Cactaceae Family 4. Traditional Use of Plants in Mexico for the Treatment of Diabetes: An Ethnopharmacological Review and Scientific Evaluations 5. Limits and Risks of Plants Valorization in Morocco Associated with Their Vernacular Names 6. Resilience of Mapuche Health System and the Influence of COVID-19 Part 2: Traditional Knowledge of Useful Plants 7. Medicinal Use of the Plants of the Atacama Desert 8. Local Botanical Knowledge of Plants Associated with Andean and Chinese Traditions in the Metropolitan Area of Buenos Aires (Argentina): An Urban Ethnobotany Study 9. Traditional Uses, Phytochemistry, and Pharmacology of Mopane (Colophospermum mopane) in Southern African Countries 10. Traditional Medicine of the Kichwa of the Upper Napo 11. Traditional Practices Regarding the Use of Botanicals to Treat Bovine Haemonchosis in Pakistan
£135.00
CRC Press Biologics and Biosimilars
Book SynopsisBiologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research and development, clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologic with high similarities in structure, efficacy, and safety, but also with potential clinical effective and cost-efficient options for the manufacturers, payers, clinicians, and patients. Most of the top-selling prescription drugs in the current market are biologics, which have revolutionized the treatment strategies and modalities for life-threatening and/or rare diseases.This book outlines the key processes and challenges in drug development, regulations, and clinical applications of biologics, biosimilars, and even interchangeable biosimilars. Global experts in the field discuss essential categories and prototype drugs of biologics and biosimilars
£45.99
Taylor & Francis Ltd HerbDrug Interactions from A to Z
Book SynopsisThis volume provides information about herb-drug interactions that may arise as a result of the increasing interest in medicinal plants or herbal products and the concomitant use of conventional drugs. Medicinal plant-drug interactions are inevitable, especially when the elderly use medicinal plant products in addition to polypharmacy. Concurrent consumption of herbal products and conventional drugs is a serious concern. Over-the-counter herbal drugâs doses can inhibit the metabolism of conventional drugs, increasing plasma levels of the drug. This book highlights evidence on herb-drug interactions from a systematic review, providing rapid access to information on their clinical use.Key Features Includes information on the interactions of selected medicinal plants with the conventional drugs that are used concurrently. Numerous evidence-based resources are available to clinicians on the safe use of herbal products. Provides general information about the pharmacokinetic and pharmacodynamic interaction mechanisms of medicinal plants and herbal products that are used concurrently with conventional medicines. Since medicinal plants and herbal products contain many bioactive compounds, interactions with conventional drugs are covered here to assist clinicians with patient safety. Focuses on the chemical constituents and their basic chemical structures of the medicinal plant parts used in folk medicine.
£47.49
Taylor & Francis Ltd HerbDrug Interactions from A to Z
Book SynopsisThis volume provides information about herb-drug interactions that may arise as a result of the increasing interest in medicinal plants or herbal products and the concomitant use of conventional drugs. Medicinal plant-drug interactions are inevitable, especially when the elderly use medicinal plant products in addition to polypharmacy. Concurrent consumption of herbal products and conventional drugs is a serious concern. Over-the-counter herbal drugâs doses can inhibit the metabolism of conventional drugs, increasing plasma levels of the drug. This book highlights evidence on herb-drug interactions from a systematic review, providing rapid access to information on their clinical use.Key Features Includes information on the interactions of selected medicinal plants with the conventional drugs that are used concurrently. Numerous evidence-based resources are available to clinicians on the safe use of herbal products. Provides general information about the pharmacokinetic and pharmacodynamic interaction mechanisms of medicinal plants and herbal products that are used concurrently with conventional medicines. Since medicinal plants and herbal products contain many bioactive compounds, interactions with conventional drugs are covered here to assist clinicians with patient safety. Focuses on the chemical constituents and their basic chemical structures of the medicinal plant parts used in folk medicine.
£47.49
Taylor & Francis Ltd Handbook of Creatine and Creatinine In Vivo Kinetics
Book SynopsisThe conceptual basis to summarize and predict the in vivo behavior and the related mathematical descriptions and models of creatine and creatinine are currently based on the principles and the methodologies of pharmacokinetics and pharmacodynamics. Most in vivo kinetic analyses and models of creatine and creatinine are assumed linear. The presence of nonlinear in vivo kinetics for creatine are assessed by the author due to the affinity and preferential uptake of the molecule in the muscle. This book is an inquiry into the application of these principles and methodologies for the endogenous compounds creatine and creatinine, and provides new pathways for studies and bench research.
£49.99
Cambridge University Press Practical Psychopharmacology
Book SynopsisAn accessible book for clinicians at all levels of training and experience who prescribe psychiatric medications and wish to better understand the rationale and empirical evidence base behind choosing treatments optimally tailored to the needs of individual patients.Trade Review'Psychopharmacology textbooks are typically either scholarly, endlessly long and inaccessible to clinicians, or clinician-friendly but with inadequate documentation for readers who want more detailed information. Somehow, Goldberg and Stahl's Practical Psychopharmacology combines the best of these two styles. It is astonishingly comprehensive with many Tables citing every relevant study while simultaneously providing the deep practical wisdom and experience of the two authors, both of whom are world class clinician-scholars. Practical Psychopharmacology also provides a sophisticated yet accessible review of the biological underpinnings of both psychopathology and medication effects. It does not just inform; it teaches the reader how to think about medications. This book will set the standard in our field for the foreseeable future.' Michael Gitlin, Distinguished Professor of Clinical Psychiatry, Director, Adult Division of Psychiatry, Director, Mood Disorders Clinic, Geffen School of Medicine at UCLA'The translation of clinical research findings into practice is fraught. The methodology of many trials is imperfect, complex, and opaque and hard to generalise to real world patients. Many critical questions are poorly answered by the extant evidence. The basic neuroscience is extraordinarily complex. This book is a Rosetta stone for translating this evidence into practice in providing a critical bridge for practising clinicians in distilling and interpreting the evidence into clear and coherent pragmatic management and prescribing recommendations. Written by two of the world's premier authorities, it is infused with a rare synergy of clinical wisdom and neuroscience expertise and is an essential resource for any practising prescriber of psychotropic agents.' Michael Berk, NHMRC Senior Principal Research Fellow; Alfred Deakin Professor of Psychiatry, School of Medicine, Deakin University and Barwon Health; Director, IMPACT, the Institute for Mental and Physical Health and Clinical Translation'Drs. Goldberg and Stahl have reminded us that they are scientific artisans by creating a pragmatic, patient-centered set of guiding principles in clinical psychopharmacology. The emergence of newer psychopharmacologic treatments and expansion of indications for previously available agents has provided hope for identifying therapeutic avenues for patients to improve their general wellbeing, but also can feel daunting, overwhelming, and a source of entropy. Consequently, it is not uncommon for clinicians at point of care to be genuinely perplexed as to which treatments and capabilities are 'promising rather than prime-time'. The authors have deftly synthesized the scientific literature and have produced a book that is comprehensive, concise, and an invaluable source of decision support at the point of care for multidisciplinary practitioners who provide care to persons with mental disorders.' Roger S. McIntyre, Professor of Psychiatry and Pharmacology and Head, Mood Disorders Psychopharmacology Unit, University of Toronto, CanadaTable of ContentsPart I. General Principles: 1. Core concepts of good psychopharmacology; 2. Targets of treatment: categories versus dimensions of psychopathology; 3. Interpreting and using the literature: integrating evidence-based trials with real-world practice; 4. Placebo and nocebo effects; 5. Tailoring the fit: moderators and mediators of treatment outcome; 6. Complex regimens and rationale-based combination drug therapies; 7. Laboratory values and psychiatric symptoms: what to measure, what not to measure, and what to do with the results; 8. Pharmacogenetics: when relevant, when not; 9. Cross-tapering and the logistics of drug discontinuation; 10. Managing major adverse drug effects: when to avoid, switch, or treat through; 11. Novel drug therapeutics: nutraceuticals, steroids, probiotics, and other dietary supplements; 12. Human diversity and considerations in special populations; Part II. Targets of Pharmacotherapy: 13. Disordered mood and affect; 14. Disorders of impulsivity, compulsivity, and aggression; 15. Psychosis; 16. Deficit states and negative symptoms; 17. Anxiety; 18. Addiction and the reward pathway; 19. Trauma and posttraumatic stress disorder; 20. Personality disorders; 21. Cognition; 22. Putting it all together; References; Index.
£55.09
Nova Science Publishers Inc Diclofenac: Pharmacology, Uses and Adverse
Book SynopsisAlthough the non steroidal anti-inflammatory agent diclofenac is an old drug, there is ongoing research interest on potential novel indications of the drug, on adverse drug reactions of diclofenac and on the management of these adverse drug reactions. This book aims to contribute knowledge on novel aspects of the pharmacology of diclofenac. Thus, the book provides evidence on three fields: (i) potential novel indications of diclofenac, especially in oncology, (ii) adverse events of diclofenac and (iii) modulation of gastrointestinal and cardiovascular toxicity of diclofenac. The book is focused on the above areas, contributing evidence on: the anticancer effects of diclofenac; the modulation of stress response by diclofenac; rare severe adverse reactions of diclofenac; thyroid effects of diclofenac; maternal and foetal adverse reactions of diclofenac and the modulation of gastrointestinal; the modulation of cardiovascular toxicity of diclofenac. All the chapters are well-written and structured and appropriately referenced. The authors present their own research work and at the same time they provide a well-informed literature review. The book will be interesting for researchers with interest in diclofenac, academic teachers, medical doctors, pharmacologists, pharmacists, and medical students.Table of ContentsPrefaceAnticancer Effects of Diclofenac: A Multitarget ApproachTargeting Stress Response with DiclofenacDiclofenac and Severe Adverse ReactionsThyroid Effects of DiclofenacThe Use of Diclofenac in Pregnancy: Fetal and Neonatal EffectsThe Use of Diclofenac in Obstetrics and Gynecology: Indications, Efficacy and Adverse EffectsNovel Approaches to Manage Toxicity of Diclofenac in the Gastrointestinal TractMitochondrial and Proteasomal Dysfunction as a Possible Mechanism of Cardiovascular Toxicity of DiclofenacIndex.
£76.49
Chelsea Green Publishing Co The LDN Book: How a Little-Known Generic Drug —
Book SynopsisCould a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more? “[LDN] raises hopes of reversing memory loss in old age.”—the Guardian Over 30,000 copies sold! Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? The LDN Book explains: The drug’s origins Its primary mechanism The latest research from practicing physicians and pharmacists Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices. The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.Trade Review“I first came across LDN several years ago when a medical colleague said I should look into its positive effects in patients with MS, Crohn’s disease, and other autoimmune disorders. I was so impressed with what I read that I helped submit a petition to the UK government to ask for funding for further research into this inexpensive drug. But, as with so many petitions, no progress was made. I hope The LDN Book—which presents up-to-date findings that again confirm the efficacy of this safe, cheap, generic drug in helping to control many chronic, disabling conditions—is read by those in the Department of Health and by all doctors caring for patients with autoimmune disease. In the UK, LDN has been stranded in limbo; maybe now the time has come for it to be accepted as a recognized therapy that could, at least, be tried on those suffering such long-term diseases of the immune system.”--Dr. Chris Steele, MBE, general practitioner; medical presenter on ITV’s This Morning“As a practicing physician who has used LDN as a cornerstone therapy for over fifteen years, I can say without equivocation that LDN is the most important and successful medicine I have ever used. I often joke that if not for LDN I couldn’t pay my mortgage; I’ve had so many new patients referred to me by someone whose life has improved dramatically through the use of LDN. And despite my knowledge and experience with LDN, I’ve learned a great deal from The LDN Book—aspects of its basic science I hadn’t known, new uses, and how its uses can inform us about the causes of various diseases. This is a wonderful book for any patient with an autoimmune disease, cancer, depression, or a host of other conditions and is a must-read for any physician whose goal is to help their patients.”--Dr. Thomas Cowan, author of The Fourfold Path to Healing and coauthor of The Nourishing Traditions Book of Baby & Child Care“Low Dose Naltrexone (LDN) was discovered by my husband and partner, Dr. Bernard Bihari. Incredibly informative and superbly written by various members of the medical profession sharing their experiences using this extraordinary drug, The LDN Book honors his legacy in helping patients suffering from autoimmune and other diseases to regain their health and their lives.”--Jacqueline Young
£19.12
SLACK Incorporated Principles of Pharmacology for Athletic Trainers
Book SynopsisPrinciples of Pharmacology for Athletic Trainers, Third Edition continues the tradition of past editions to provide applications of pharmacological principles specifically aimed at the athletic trainer. The drug categories that are included are primarily those that may be pertinent to the treatment of athletic injuries or that may affect athletic performance.Drs. Joel Houglum, Gary Harrelson, and Teresa Seefeldt have taken a unique aspect to the organization and design of the Third Edition to be instructional discussions regarding the use and effects of drugs and of the disease states treated by these drug categories. Additionally, there is a specific discussion of the role of the athletic trainer regarding the therapeutic use and effects of these drugs.Features of the Third Edition: Satisfies all of the CAATE Educational Competencies on pharmacology Advanced organizers and specific learning objectives at the beginning of each chapter Summaries after each major topic within the chapter Case studies and clinical applications Discussion on popular fitness supplements Key words are in italics and defined in the glossary Concept maps present important, yet complex, processes in a concise, graphical way Shaded textboxes throughout include additional information and are beneficial for the reader to recall a key concept addressed in an earlier chapter New ancillary materials specifically for faculty that include PowerPoint slides and test bank questions for each chapter Instructors in educational settings can visit www.efacultylounge.com for additional materials to be used for teaching in the classroom.Principles of Pharmacology for Athletic Trainers, Third Edition will continue to be the go-to resource to determine the best pharmacological treatment strategy and management by athletic trainers.Trade Review“This is a very useful book for athletic training students. Traditionally they would have to use books that didn't focus on the profession of athletic training and would be much more difficult to follow. The book is unique in carving out the most common drug therapies seen in athletic populations and providing basic principles of the effects of using any pharmacologic agent. It also does a great job outlining federal law and the degree to which it is legal for athletic trainers to dispense. All areas are covered with just enough detail for athletic trainers to be able to devise a protocol for their specific location or practice. This update is necessary because of the changes in the law and in the profession, as well as newer concepts such as pharmacogenetics.” - Mary E. Vander Heiden, MA, ATC, LAT, University of Central Florida,Doody’s Review ServiceTable of ContentsDedicationAbout the AuthorsContributing AuthorsPreface Chapter 1 Introduction to Pharmacology Chapter 2 Pharmacokinetic Principles: Processes That Affect Drugs From Entry to Exit Chapter 3 Pharmacodynamic Principles: Mechanism of Drug Action and Therapeutic Considerations Chapter 4 Medication Management in an Athletic Training Facility Alan D. Freedman, MEd, ATC Chapter 5 Drugs for Treating Infections Chapter 6 Drugs for Treating Inflammation Chapter 7 Drugs for Treating Pain Chapter 8 Drugs for Relaxing Skeletal Muscle Chapter 9 Drugs for Treating Asthma Chapter 10 Drugs for Treating Colds and Allergies Chapter 11 Drugs for Treating Gastrointestinal Disorders Chapter 12 Drugs for Treating Hypertension and Heart Disease Chapter 13 Drugs for Treating Psychiatric Disorders Chapter 14 Drugs for Treating Diabetes Mellitus Chapter 15 Herbal and Fitness Supplements Chapter 16 Performance-Enhancing Drugs Michael Powers, PhD, ATC, CSCS, EMT Chapter 17 Drug Testing in Sports Cindy Thomas, MS, AT-R and Nathan Burns, MS, ATC Pharmacological AbbreviationsGlossaryFinancial DisclosuresIndex
£81.70
Elsevier Science & Technology Transporters in Drug Discovery and Development: Detailed Concepts and Best Practice
Book SynopsisWritten by a leading researcher in the field, Transporters in Drug Discovery and Development provides a comprehensive and practical guide to drug transporter families that are the most important for drug discovery and development. It covers: an overview of transporter families and organ distribution; clinical relevant drug-drug interaction; clinical relevant polymorphism; drug transporter related pharmacokinetic, pharmacodynamics and toxicity; in vitro/in vivo probes of drug transport studies; the practical methodologies of industrial transporter screening and translational aspect in drug discovery and developments.Table of ContentsMembrane transporters and the diseases corresponding to functional defects; P-glycoprotein (P-gp/MDR1)/ABCB1; Multidrug resistance- associated protein 2 (MRP2/ABCC2); Breast cancer resistance protein (BCRP)/ABCG2; The bile salt export pump (BSEP/ABCB11); Organic anion- transporting polypeptides (OATPs/SLCOs); Organic anion, organic cation and zwitterion transporters of the SLC22 and SLC47 superfamily (OATs, OCTs, OCTNs and MATEs); Drug transporters in drug discovery and development; Transporter study methodologies.
£183.61
M&K Update Ltd Pharmacology Case Studies for Nurse Prescribers
Book Synopsis
£42.75
Scribe Publications Fentanyl, Inc.: how rogue chemists are creating
Book SynopsisA TELEGRAPH BOOK OF THE YEAR. An undercover investigation into the synthetic-drug epidemic. A new group of chemicals is radically transforming the recreational-drug landscape. Known as novel psychoactive substances (NPS), they range from so-called ‘legal highs’ like Spice, to synthetic opioids – most famously, the deadly fentanyl. Designed to replicate the effects of established drugs like cocaine, ecstasy, marijuana, and heroin, NPS are synthesised in laboratories. They are cheap to produce and easy to transport. They are also extremely potent and often deadly. Originally developed for medicinal purposes, and then hijacked by rogue chemists, who change their molecular structures to stay ahead of the law, these chemicals’ effects can be impossible to predict. What we do know is that they have triggered the biggest drug epidemic that America has ever seen, and which is now spreading internationally. In Fentanyl, Inc., award-winning journalist Ben Westhoff goes undercover to investigate the shadowy world of synthetic drugs — becoming, in the process, the first journalist to infiltrate a Chinese fentanyl lab. He tracks down the drug baron in New Zealand who unintentionally helped to start the synthetic-drug revolution; prowls St. Louis streets with a former fentanyl dealer to understand how the epidemic started; and chronicles the lives of addicts and dealers, families of victims, law enforcement officers, and underground drug-awareness organisers in the US and Europe. Fentanyl, Inc. is essential reading on a global calamity we are only just beginning to understand.Trade Review‘It’s a sucker-punch of a read … Westhoff exposes, with cinematic scope and reams of data, a new epidemic.’ -- Harriet Alexander * The Daily Telegraph *‘Groundbreaking.’ -- Eleanor Halls * The Telegraph *‘An eye-opening work of journalism, informed on the legal and pharmaceutical aspects without losing sight of the human cost.’ -- Alastair Mabbott * The Herald *‘A fascinating book.’ -- Seán Moncrieff * The Moncrieff Show *‘Through his courageous reporting, Ben Westhoff takes us to the heart of the problem. In Fentanyl, Inc. he shines a light on the human wreckage and damage caused by the most powerful and dangerous of the opioids, fentanyl, and its derivatives. He shows us how addiction, mislabeling, purposefully or mistakenly mixed drugs lead to tragic ends. The drug is often created out of factories operating with the permission of the Chinese government. To solve this epidemic, we must understand it. Make no mistake; the fentanyl problem is a global issue. Fentanyl, Inc. is a must-read, pulling the curtain back and showing us how this human tragedy occurs and how insidious and addictive a drug can be.’ -- Katherine Tobin, PhD, Former Member of the U.S.-China Economic & Security Review Commission‘A necessary and sobering look at the opioid crisis and how it is not as simple as it appears on the surface. Well-researched and user-friendly for all readers. An important book.’ -- Debra Ginsberg * Bay Books *‘Drawing material from official reports, drug databases, scores of interviews, and years of personal research, Westhoff presents an unflinching, illuminating portrait of a festering crisis involving a drug industry that thrives as effectively as it kills. Highly sobering, exemplary reportage delivered through richly detailed scenarios and diversified perspectives.’ STARRED REVIEW * Kirkus Reviews *‘This is an exceptionally useful and well-timed book. I hope anyone concerned about this era’s new addiction epidemic will read it and put its messages to use. Ben Westhoff very skilfully combines pharmacology, politics, law enforcement, and gripping international intrigue in his account of America’s number-one public health problem. I hope Fentanyl, Inc. is widely read and influential.’ -- James Fallows, award-winning journalist and author of China Airborne‘In Fentanyl, Inc., Ben Westhoff lays bare the twisted history that led to opioids wreaking havoc on twenty-first century America. If you want to understand the bloody cycle of addiction and death gripping the nation, you need to read this book.’ -- Ioan Grillo, author of El Narco and Gangster Warlords‘An information-packed work of reporting that traces the rise of designer drugs, including synthetic and/or more dangerous versions of weed, acid, and heroin, the last of which gives the book its title. Fentanyl, a synthetic opioid that’s chemically similar to morphine and heroin, is the top cause of fatal drug overdoses in the United States. The most illuminating parts of the book are those that reveal the business practices of Chinese labs that supply illicit fentanyl to U.S. dealers. These labs are a source of death and destabilisation for our country, American officials say, while Chinese leaders contend that it’s on us to deal with Americans’ appetite for the stuff.’ -- Francie Diep * Pacific Standard *‘Westhoff explores the many-tentacled world of illicit opioids, from the streets of East St. Louis to Chinese pharmaceutical companies, from music festivals deep in the Michigan woods to sanctioned ‘shooting up rooms’ in Barcelona, in this frank, insightful, and occasionally searing exposé ... Offers a truly multifaceted view of the landscape of fentanyl use and abuse. The disparate narrative strands he weaves together — including tragic stories of drug users, straightforward analysis of the history of opioid use, tension-filled episodes of drug runs and supplier meet-ups, and the humane and hopeful work of the ‘harm reduction’ movement—all come together to provide a more complex understanding of the rise of, and response to, the opioid epidemic. Westhoff’s well-reported and researched work will likely open eyes, slow knee-jerk responses, and start much needed conversations.’ * Publishers Weekly *‘Excellent’ -- Mary Wakefield * The Spectator *‘Will assist policymakers, activists, and general readers in understanding better how to respond to the drug crisis that is only more intractable now.’ * Library Journal *‘So many substance abuse books are a mix of hysterical in tone and a disappointing ‘paint by numbers’ in their execution, but [Fentanyl, Inc.] really stands out for its research, journalism, and overall analysis ... It is also a great book on China, and how China and the Chinese chemicals industry works, backed up by extensive original investigation ... Definitely recommended.’ -- Tyler Cowen * Marginal Revolution *‘Timely and agonising … [Westhoff’s] book is the product of a four-year deep-dive into the world of designer drugs, and it’s an impressive work of investigative journalism. He interviewed 160 people and visited laboratories all over the world; he even infiltrated a pair of Chinese drug operations.’ * USA Today *‘A history lesson on American drug use and drug laws, a crash course in chemistry and neuroscience, a multifaceted portrait of addiction, and a look at how harm reduction programs can atone for the failures of the War on Drugs … A finely woven and accessible analysis of the connection between university chemistry professors, dark web sales, drug cartels, law enforcement, and the dealers and addicts dependent on it … Westhoff is a skilled and empathetic biographer, and this gift serves the composite of the dealers, users, and bereaved of Fentanyl, Inc. … It’s in this focus on the human cost of the crisis, of empathy over criminalisation, that this accomplished book feels most urgently important.’ * St. Louis Post-Dispatch *‘The most frightening book of the year, and it’s mandatory reading … Epic … This is a story about people, and Fentanyl, Inc. features a roster of villains and victims who stray far from movie archetypes.’ * Dig Boston *‘Setting Fentanyl, Inc. apart from most other books that focus on the supply-side of illegal drugs, Westhoff smartly avoids pro-drug-war narratives that push for an intensified law-and-order response to the proliferation of more potent synthetic drugs … The War on Drugs and misguided law enforcement efforts have not stemmed the spread of fentanyl, but instead have contributed to its takeover, Westhoff carefully explains.’ * Filter *‘Extensively reported and vividly written … Westhoff elevates his impressive examination of the opioid epidemic by reporting on the US government’s failed war on drugs and the promise of innovative ‘harm reduction’ policies that recognise that ‘Just Say No’ is a losing proposition.’ * National Book Review *‘Westhoff looks at the new wave of synthetic drugs that are taking the opioid epidemic to a whole new deadly level. He managed to go undercover into one of the many labs in China where these drugs are being manufactured, and the results of his research there and elsewhere are terrifying … Anyone who is interested in learning more about the opioid crisis, or has read Dopesick, is going to want to check this out.’ * Omnivoracious, the Amazon Book Review *‘A detailed and far-ranging investigation into the production, marketing, and usage of fentanyl reveals an intertwined business network that spans continents and kills thousands.’ * Shelf Awareness *‘In this gripping investigation, Westhoff recounts the deadly consequences of synthetically made drugs and how this phenomenon is beginning spread internationally.’ * Happy Mag *‘The way [Fentanyl, Inc.] looked at every aspect of the novel psychoactive substance trade was unique. From chemists manipulating chemical structures of precursors to fentanyl before countries can ban them, to the dealers, end users and those who want to change the way addiction is treated, Westhoff details it all ... this book is an eyeopener to anyone who reads it of just how coordinated and advanced the illicit drug trade is in aiming to get new highs to market at any cost.’ * Sam Still Reading *‘Fentanyl, Inc. is a wake-up call to us all. Shocking and unnerving.’ -- Judith Baragwanath * Noted *‘The information uncovered by Westhoff, an investigative reporter, will no doubt prove useful to lawmakers, addiction counsellors, and anyone else who is dealing with opioid addiction ... But where the book really shines is in Westhoff’s ability to get inside the lives of his characters, from addicts like Henke and Schwandt, to the scientists who initially developed opioids, to the Chinese chemists who are manufacturing fentanyl knockoffs — and profiting hugely off the global rise of opioid addiction ... a feat of reporting, to be sure. And while the many details Westhoff uncovered are likely to leave some readers enraged, Fentanyl, Inc. is an important book that arrives at a key juncture in the opioid crisis.’ -- Arlene Weintraub * The New York Journal of Books *‘[E]pic ... like Breaking Bad, sure — meets Night of the Living Dead meets New Jack City, Gummo, Kids and Gremlins, with a cast from a lot of the places on President Donald Trump’s ‘shithole’ list ... Westhoff includes ample relevant history.’ -- Chris Faraone * Little Village *‘A really fascinating book on a terrifying subject.’ * Joe Rogan *‘Excellent … Readable and alternately engaging and chilling in its account of the development, deployment, and devastating consequences of NPS … Politicians, police, and the public continue to debate how to handle the use of psychoactive substances in our culture and legal system. Westhoff’s Fentanyl, Inc. should be required reading for anyone who wishes to contribute to a knowledgeable discussion.’ * Winnipeg Free Press *‘A fascinating look into how China is playing a major role in the spread of fentanyl across the US. The book connects the dots between the pharmaceutical companies and their role in the opioid crisis with the Chinese labs manufacturing the illicit fentanyl and manoeuvring it through Mexico to get it into the US. Highly recommend it!’ * Yahoo Finance *Praise for Original Gangstas ‘I trust Ben Westhoff. I trust him to report a story and I trust him to tell a story, and that's exactly what he's done here in Original Gangstas. He's taken what's always felt like an almost impossibly knotted string of storylines and plot points in gangsta rap, the most turbulent version of the most popular music on the planet, and turned them into an airtight and unflinching book. Original Gangstas is as resolute as the people and ideas it sets out to profile, and that is no small feat.’ -- Shea Serrano, New York Times bestselling author of The Rap Year BookPraise for Original Gangstas ‘A provocative, multifaceted portrait of essential rap pioneers who ushered the hip-hop music scene to greatness … As raw, authoritative, and unflinching as the music his narrative chronicles, Westhoff comprehensively uncovers the factual roots of the gangsta rap movement and admirably credits those whose footprints paved the way for the younger rappers emerging today … An elaborately detailed, darkly surprising, definitive history of the LA gangsta rap era.’ STARRED REVIEW * Kirkus *Praise for Dirty South ‘Packed with lively reporting and colourful social history … doesn't shy away from the bigger questions. Westhoff grapples with Southern rap's troubling racial politics and takes on the critics.’ * Rolling Stone *
£17.09
Waterside Press Drug Science and British Drug Policy: Critical
Book SynopsisFor half a century the Misuse of Drugs Act 1971 has dominated ill-conceived approaches to the prohibition of drugs and the criminalisation of many offenders. Wilful blindness to scientific facts has distorted the dispensation of justice, prevented lifesaving investigation, sidelined critics and thwarted advocates of politically inconvenient drugs law reform. This once in an epoch review by experts from a range of disciplines shows how lawmakers and the media have ignored the scientific evidence to sustain badly founded rhetoric in favour of blanket bans, punishment and the marginalisation of opponents. Countless individuals (including the vulnerable, deprived, addicted and mentally ill) have therefore suffered unnecessarily. This, the most comprehensive critique of the 1971 Act yet, rests on the combined learning of leading medical, scientific, psychiatric, academic, legal, drug safety and other specialists to provide sound reasons to re-think half a century of bad law.Trade Review'It is time to see the MDA 1971 for what it is: a bad law that has the opposite effect to that intended. The so-called war on drugs is lost. It could never be won. Let us replace this knee-jerk law with something rational, something evidence-based, something more humane.'- From the Foreword.Table of ContentsForeword by The Rt Hon Norman Baker; Introduction. PART I - The Impact Of Drugs: At the Frontiers of Psychiatry; A Forensic Science Perspective; Fifty Years of MDMA; Displacement, Adulteration and Innovation - How the MDA 1971 Failed to Control NPS; Cannabis: Past, Present and Future; Narratives of Drug-related Harm. PART II - Impact on the Medical, Pharmacy and Veterinary Professions: Chronic Pain; The Impact of the MDA 1971 on the Veterinary Profession; Enabling Access to Essential Medicines and Devices. PART III - Legacies of the Drug Laws: How States Have Adapted Their Drug Laws; The Sixties, Barbara Wootton and the Counterculture - Revisiting the Origins of the MDA 1971; The Ongoing Impact on the Racialised Policing of Black Communities. PART IV - Perspectives and Approaches: Challenging Stigma, Changing Minds; The MDA 1971: No Education; The Impact of Drug Legislation on Climate Change; Decision Conferencing and Multi-criteria Decision Analysis; The MDA 1971: Missteps and Misunderstandings. PART V - Changing Policy: Regulating the Legal: Lessons from Alcohol Policy and the Battle for Minimum Unit Pricing in Scotland; A Modest Proposal to Decriminalise the Simple Possession of Drugs; The Legal Regulation of Drugs in the UK. Index.
£23.75
Springer Nature Switzerland AG Human Challenge Studies in Endemic Settings:
Book SynopsisThis open access book provides an extensive review of ethical and regulatory issues related to human infection challenge studies, with a particular focus on the expansion of this type of research into endemic settings and/or low- and middle-income countries (LMICs). Human challenge studies (HCS) involve the intentional infection of research participants, and this type of research is rapidly increasing in frequency worldwide. HCS are widely considered to be an especially promising approach to vaccine development, including for pathogens endemic to LMICs. However, challenge studies are sometimes controversial and raise complex ethical issues, some of which are especially salient in endemic and/or LMIC settings. Informed by qualitative interviews with experts in infectious diseases and bioethics, this book highlights areas of ethical consensus and controversy concerning this kind of research. As the first volume to focus on ethical issues associated with human challenge studies, it sets the agenda for further work in this important area of global health research; contributes to current debates in research ethics; and aims to inform regulatory policy and research practice. Insofar as it focuses on HCS in (endemic) settings where diseases are present and/or widespread, much of the analysis provided here is directly relevant to HCS involving pandemic diseases including COVID19. Table of Contents1. Introduction.- 2. Methods.- 3. History of human challenge studies.- 4. ethical issues.- 5. Community engagement, ethics review, and regulation.- 6. Case studies.- 7. Conclusions.- Acknowledgements.
£13.49
Globeedit Enkelvoudige orale medicatie van Albendazole &
Book Synopsis
£39.35
General Press India Scientific Healing Affirmations
£11.62
World Scientific Publishing Co Pte Ltd Cobert's Manual Of Drug Safety And
Book SynopsisCompletely revised and updated, Cobert's Manual of Drug Safety and Pharmacovigilance, Third Edition, is a how-to manual for those working in the fields of drug safety, clinical research, pharmacology, regulatory affairs, risk management, quality/compliance, and in government and legal professions.This comprehensive and practical guide discusses the theory and the practicalities of drug safety (also known as pharmacovigilance), and provides essential information on drug safety and regulations in the United States, Europe Union, and more, including: recognizing, monitoring, reporting, and cataloging serious adverse drug reactions.Cobert's Manual of Drug Safety and Pharmacovigilance, Third Edition, teaches the daily practice of drug safety in industry, hospitals, the FDA and other health agencies — both in the United States and around the world — and provides critical information about what to do when confronted with a drug safety problem.Related Link(s)
£49.50
Hodder & Stoughton Say Why to Drugs
Book SynopsisA definitive and authoritative guide to drugs and why we get high from the creator of the top-rated podcast, Say Why to Drugs. Drugs. We''ve all done them. Whether it''s a cup of coffee or a glass of wine, a cigarette or a sleeping pill. But how well do we understand the effects of the drugs we take - legal or illegal? Say Why to Drugs investigates the science behind recreational drugs- debunking common myths and misconceptions, as well as containing the most recent scientific research. Looking at a range of drugs, this book provides a clear understanding of how drugs work and what they''re really doing to your mind and body. Along the way you will find out why ketamine is on the WHO''s list of essential medicines, why some researchers hope MDMA could treat PTSD, and much more. Enlightening, entertaining, and thought-provoking, Say Why to Drugs is a compelling read that will surprise and educate proponents on both sides of the drugs debatTrade ReviewSuzi Gage cuts through all the sensationalism and goes straight into an erudite, evidence based breakdown. In an area where factual accuracy is often rejected in favour of moralising or panicking this book is a vitally useful and frequently fascinating. -- Robin InceAn essential read. Drugs have a huge impact on our society. Whether you're taking them on not, it's good to be informed. -- Tim LovejoyAn excellently written, ironically clear-headed, and much needed book... that tells you all the important stuff worth knowing about drugs. -- Dean Burnett, author of The Idiot Brain and The Happy Brain It's so refreshing to read a book about drugs which fully acknowledges the complex, nuanced psychological aspects of addiction and that we're all somewhere on that scale. Written without making sweeping moral judgements and faithful to the science, this is a great overview for anyone who wants to educate themselves on a massive (and often emotive) topic. -- Natasha Devon, LBC
£10.44
Pharmaceutical Press Integrated Pharmacy Case Studies
Book SynopsisThis innovative new textbook is one of the first to integrate the science of pharmacy with practice. Integrated Pharmacy Case Studies provides a case study approach to pharmacy education, demonstrating in the most practical way possible the relevance of pharmaceutical science in practice.
£44.65
Pharmaceutical Press Remington Education Physical Pharmacy
Book SynopsisRemington Education: Physical Pharmacy provides a simple, concise view of the concepts and applications of physical pharmacy.Trade Review"The study of physical pharmacy often fills many students with trepidation but this book, published by Pharmaceutical Press, Royal Pharmaceutical Society, can help to alleviate this by providing a simple introduction to the topic. The author defines physical pharmacy as a subcategory of pharmaceuticals that focuses on the reasons that drug delivery systems behave as they do...The book is laid out in an easy to understand way, guiding the reader through each relevant component. By providing a summary of important information and including self-assessment questions and answers, the book offers a practical way for students to check knowledge and track progress before, during and after a course in physical pharmacy." Laurence A. Goldberg, The Pharmaceutical Journal, 22 December 2015 -- Laurence A. Goldberg * The Pharmaceutical Journal *Table of Contents1: Intermolecular Interactions; 2: Colligative Properties of Substances; 3: Solvents; 4: Solutions; 5: Interfacial Phenomena and Rheology; 6: Colloids; 7: Coarse Dispersions - Suspensions; 8: Coarse Dispersions - Emulsions; 9: Semisolid Drug Delivery Systems; 10: Powders and Granules; 11: Capsules; 12: Tablets; 13: Suppositories; 14: Transdermal Products; 15: Ophthalmic, Otic, Nasal Drug Delivery Systems; 16: Inhalation Drug Delivery System.
£36.10
Pharmaceutical Press Physicochemical Principles of Pharmacy
Book SynopsisThis established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.Trade Review"The text is highly illustrated throughout and includes key points and appropriate examples, providing clinicians with some easily accessible and relevant information. Some examples of adverse events due to excipients, impurities, the influence of dosage forms, materials in delivery devices and even light-induced effects are also included. Although the detection of adverse events is not an easy task, these examples may assist clinicians in asking the right questions to predict or identify adverse effects. The new focus on applications to clinical practice in this edition has extended its usefulness from pharmacy and pharmaceutical scientist courses to clinicians seeking an understanding of formulations, especially for children and older people, and in identifying the cause of adverse events."Beverley Glass, Australian Prescriber October 2016 -- Beverley Glass * Australian Prescriber *
£45.60
Jessica Kingsley Publishers Aromatherapeutic Blending: Essential Oils in
Book SynopsisSynergistic blending is at the very core of aromatherapy practice. This book explores the concept of synergy and the evidence for its presence and significance, and provides practical guidance on how to build aromatherapeutic blends effectively and safely based on research evidence.The author covers new and exciting developments in research into the use of essential oils, explores the merits and limitations of holistic, psychosensory and molecular approaches to blending and suggests effective ways of choosing the most suitable approach for individual clients. Evidence-based profiles of essential oils and absolutes are included and the comprehensive tables summarising their actions enable practitioners to identify easily potential contenders for synergistic blends.Throughout the book, the author encourages students and practitioners of all levels to reflect on their practice, appraising the intended outcomes of their blends and treatment plans, so that they can emerge more knowledgeable and insightful practitioners.Trade ReviewThe wealth of information on essential oils contained within this book make it an indispensable reference for all aromatherapists, and others interested in essential oils. Jennifer Rhind draws from her many years of study, experience and exploration, and combines her insights with a rigorous scientific understanding to shed new light on the actions and character of individual essential oils, together with ideas on how best to combine them into therapeutic blends. Highly recommended. -- Gill Farrer-Halls, LLSA, MIFA, author of 'The Spirit in Aromatherapy' and 'The Aromatherapy Bible'In Aromatherapeutic Blending, Jennifer Rhind explores this fascinating subject from a variety of angles, including up-to-date scientific data, the bio-chemical interaction of essential oils, individual case studies and her own experiential expertise. The material detailed in Part II, Essential Oils & Absolutes: Actions & Evidence, presents a unique contribution to aromatherapy literature and provides a valuable resource for all those involved in creating effective synergy blends. I can highly recommend this book as a well-researched reference source, as well as a practical guide to blending. -- Julia Lawless, aromatherapist, author of 'The Encyclopedia of Essential Oils' and Managing Director of Aqua OleumAromatherapeutic Blending is a book that every aromatherapy practitioner should own and every aromatherapy educator should incorporate into their curriculum. The author takes you on a journey that encompasses and reviews various approaches to aromatherapetic blending and then compares and contrasts them. She provides a summary of relevant discussion of what we (as aromatherapists) have learned from many teachers and schools of thought over time; including various models of client assessment, blending and care. What is refreshing is that alongside the chemistry and biology, the author encourages the reader to discover (or renew) their relationship with plants and the personality and aromatic impact of the essential oils they provide. This book is not a "re-telling" of information, but rather a presentation of many approaches to provide a meaningful exploration, leaving it to the reader to determine what fits best into his/her holistic practice. In addition to providing current information to support the text, she provides key reflective points serving as a catalyst for a dynamic discussion between teacher and student or between colleagues. This is not a book for passive learners, but rather those who want to fully engage in the process of learning about the essential oils and their therapeutic benefits. -- Lora Cantele, Editor/Publisher of The International Journal of Professional Holistic AromatherapyRhind's enthusiastic approach makes for compelling reading from a scientific and holistic point of view. It is a useful functional aid for inspirational blending and a great reference for evidence-based practice. I would recommend it for students and well-versed aromatherapists alike and will be adding it to my recommended reading list for future aromatherapy students. -- Rachel Langford * International Therapist *[This book] gives the reader a tool, or method, on how to bring these aromas, or essential oils, together in a synergistic blend to address the physical and emotional issues we may experience during life (...) this book gives you some techniques for perfecting aromatherapy blends for such conditions as acne, pain, inflammation, infections, wounds, allergies, anxiety, and depression. -- Sharon Falsetto * NAHA Aromatherapy Journal, Winter 2017.4 *Table of ContentsPreface. Acknowledgements. Introduction. Part I. Principles and Practice. 1. Essential oil synergy. 2. The individual prescription. 3. A spectrum of approaches: science-based, psychosensory and vitalistic paradigms. 4. Aromatherapeutic blending. 5. Applications, carrier media, dosage and ratios. 6. Acne vulgaris: a case study. Part II. Essential oils: Actions and Evidence. 7. Pain and Inflammation: analgesic and anti-inflammatory actions. 8. Smooth Functioning: antispasmodic, vasorelaxant, antihyperlipidemic and anticonvulsant actions. 9. Health Maintenance and Enhancement: antioxidant and anti-cancer actions. 10. Infection and Immunity: antimicrobial and immunomodulant actions. 11. Respiratory Support: expectorant, mucolytic, decongestant and antitussive actions. 12. The Skin and Soft Tissues: wound-healing, anti-allergic and antipruritic actions. 13. The Psyche: anxiolytic, antidepressant and cognition-enhancing actions. Part III. Aromatics. 14. Essential oils and Absolutes: evidence-based practice. 15. Expanded Practice Aromatics: abbreviated profiles for synergistic blending. Afterword. Appendix. Fixed and Macerated Oils in Aromatherapy. Glossary. References. Recommended Texts and Further Reading. Resources.
£27.99
Elsevier Science Publishing Co Inc Drugs During Pregnancy and Lactation
Book SynopsisTrade Review"Geared to an international audience, this desk reference for medications and how they affect pregnancy and lactation does a solid job of highlighting the pertinent information while covering worthwhile medications. Score: 70 - 3 Stars" --Doody's "A welcome edition to an already thorough reference...succinct texts such as this are invaluable and worthy of a spot on a bookshelf of any health care practitioner who advises pregnant or lactating women." --Myla Moretti, Motherisk Program, Toronto, Ontario, in Canadian Journal of Hospital PharmacyTable of Contents1. General Commentary on drug therapy and drug risks in pregnancy 2. Specific drug therapties during pregnancy 2.1 Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications 2.2 Allergy and hyosensitization therapy 2.3 Antiasthmatic and cough medication 2.4 Nausea and vomiting in pregnancy 2.5 Gastro-intestinal medications, hyoplipidemic agents and spasmolytics 2.6 Anti-infective Agents 2.7 Vaccines and immunoglobulins 2.8 Heart and blood medications 2.9 Anticoagulants, thrombocyte aggregation inhibitors, fibrinolyrics,and volume replacement agents 2.10 Epilepsy and antiepileptic medications 2.11 Psychotropic drugs 2.12 Immunosuppression, rheumatic diseases, multiple sclerosis, and Wilson's disease 2.13 Antineoplastic drugs 2.14 Uterine contraction agents, tocolytics, vaginal therapeutics and local contraceptives 2.15 Hormones 2.16 General and local anesthetics and muscle relaxants 2.17 Dermatological medications and local therapeutics 2.18 Vitamins, minerals and trace elements 2.19 Herbs during pregnancy 2.20 Diagnostic agents 2.21 Recreational drugs 2.22 Poisonings and toxins 2.23 Occupational, industrial and environmental agents 3. General commentary on drug therapy and drug risk during lactation 3.1 The advances of breastfeading versus the risks of maternal medication 3.2 The passage of medication into the mother's milk 3.3 Infant characteristics 3.4 Milk plasma ratio 3.5 Amount of medication in the milk and relative dose 3.6 Toxicity of medications in the mother's milk 3.7 Medications that affect lactation 3.8 Breastfeeding support 4. Specific drug therapies during lactation 4.1 Analgesics, antiphlogistics and anesthetics 4.2 Antiallergics, antiasthmatics and antitussives 4.3 Gastrointestinal drugs 4.4 Anti-infectives 4.5 Vaccines and immunoglobulins 4.6 Cardiovascular drugs and diuretics 4.7 Anticoagulants, thrombocyte aggregation inhibitors and fibrinolytics 4.8 Antiepileptics 4.9 Psychotropic drugs 4.10 Immunomodulating and antineoplastic agents 4.11 Hormones and hormone antagonists 4.12 Dermatological medication and local therapeutics 4.13 Alternative remedies, vitamins, and minerals 4.14 Contrast media, radionuclides and diagnostics 4.15 Infections during breastfeeding 4.16 Recreational drugs 4.17 Plant toxins 4.18 Industrial chemicals and environmental contaminants 4.18.1 Persistent organochlorine compounds (pesticides, polychlorinated biphenyls and dioxins) 4.18.2 Mercury 4.18.3 Lead 4.18.4 Cadmium 4.18.5 Other contaminants 4.18.6 Breasfeeding despite environmental contaminants? 4.18.7 Breastfeeding and the workplace
£58.50
Elsevier Science How to Optimize Fluid Bed Processing Technology
Book SynopsisTable of Contents1. Introduction2. Fluidization Theory3. Fluid Bed Processor Equipment and Its Functionality4. Process Development5. Granulation6. Drying7. Coating8. Pelletization9. Other Fluid Bed Processes and Applications10. Process Control and PAT11. Process Scale-Up12. Integrated Systems13. Process Troubleshooting14. Fluid Bed Safety
£44.99
Elsevier Science Surfactants in Biopharmaceutical Development
Book SynopsisTable of Contents1. Introduction 2. Polysorbate Surfactants used in biopharmaceuticals: An overview including in vivo fate and toxicology perspective 3. Surfactants (polysorbate and poloxamer) synthesis and degradation: Overview and relevance 4. Mechanisms of stabilization of proteins by surfactants 5. Behaviour of surfactant during processing (UF/DF, filter adsorption) 6. Analytical methods for surfactant characterization in Drug Product 7. Oxidative degradation of surfactants: Mechanisms 8. Hydrolytic degradation of surfactants and impact on protein stabilization 9. Regulatory Perspective on Surfactant Monitoring and Control 10. Control strategies to address surfactant degradation: A quality perspective 11. A look to the future - closing remarks
£121.50
Oxford University Press Oxford Handbook of Practical Drug Therapy
Book SynopsisThis Handbook mirrors the leading national guides to prescribing. The safe and effective use of medicine requires a sound knowledge of pharmacology. As readers use this practical book, they will increase their knowledge.Trade ReviewI would recommend the Oxford Handbook of Practical Drug Therapy for both use on the wards and for revision for medical school exams. . . Its in depth cover of relevant prescribing information will make it a useful resource for junior doctors as well as medical students. * Lucy Faulkner, Northwing Magazine Sheffield University Medical Students Magazine *This is a small compact and easy to utilise drug therapy manual. Overall a well set out easy to follow guide that would be useful for health professionals of all levels. * ANTS Bulletin *Table of ContentsIntroductory sections ; 1. Gastrointestinal system ; 2. Cardiovascular system ; 3. Respiratory system ; 4. Central nervous system ; 5. Infections ; 6. Endocrine system ; 7. Kidneys and the urinary tract ; 8. Malignant disease and immunosuppression ; 9. Nutrition and blood ; 10. Musculoskeletal and joints ; 11. Eye ; 12. Skin ; 13. Poisoning ; 14. Immunological products and vaccines ; 15. Relief of pain and anaesthetic drugs
£32.29
Springer Science+Business Media Modern Electrochemistry 2B Electrodics in Chemistry Engineering Biology and Environmental Science
Book SynopsisThis book had its nucleus in some lectures given by one of us (J. O''M. B. ) in a course on electrochemistry to students of energy conversion at the University of Pennsyl- nia. It was there that he met a number of people trained in chemistry, physics, biology, metallurgy, and materials science, all of whom wanted to know something about electrochemistry. The concept of writing a book about electrochemistry which could be understood by people with very varied backgrounds was thereby engendered. The lectures were recorded and written up by Dr. Klaus Muller as a 293-page manuscript. At a later stage, A. K. N. R. joined the effort; it was decided to make a fresh start and to write a much more comprehensive text. Of methods for direct energy conversion, the electrochemical one is the most advanced and seems the most likely to become of considerable practical importance. Thus, conversiTrade Reviewabout the First Edition: `A superbly written teaching book which should become indispensable to every student of electrochemistry.' Journal of the American Chemical Society `A truly extraordinary achievement ... An enormous body of electrochemical knowledge and a wealth of stunningly penetrating detail.' Journal of the Electrochemical Society `A must.' Nature about the second edition: `These original, stimulating and informative volumes offer an unusual approach and inter alia provide an excellent entrée to the field for the non-specialist.' Emeritus Professor Douglas Inman, Dept. of Materials, Imperial College, LondonTable of Contents10. Photoelectrochemistry. Appendix 1: A Brief Note on Electroluminescence and Electroreflectance. Appendix 2: Electrochemical Preparation of Semiconductor Electrodes. Appendix 3: High Desolution Techniques in the Study of Semiconductor Surfaces. 11. A Few Selected Aspects of Organo-Electrochemistry. Source of Further Information on Organo-Electrochemistry. 12. Charge Transfer, Surface and Civilization. 13. Electrochemical Energy Conversion and Storage. More on the Storage of Electricity. 14. Bioelectrochemistry. Appendix: Dynamic Membrane Potentials. 15. Environmentally Oriented Electrochemistry.
£999.99
National Academies Press Risk Communication and Vaccination Workshop Summary Compass Series
a huge range and FREE tracked UK delivery on ALL orders.
£83.29
National Academies Press Adverse Effects of Vaccines
Book SynopsisIn 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed in 1986, was intended to bolster vaccine research and development through the federal coordination of vaccine initiatives and to provide relief to vaccine manufacturers facing financial burdens. The legislation also intended to address concerns about the safety of vaccines by instituting a compensation program, setting up a passive surveillance system for vaccine adverse events, and by providing information to consumers. A key component of the legislation required the U.S. Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse events, especially in children. Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological eviTable of Contents1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Approach; 5 3 Evaluating Biological Mechanisms of Adverse Events; 6 4 Measles, Mumps, and Rubella Vaccine; 7 5 Varicella Virus Vaccine; 8 6 Influenza Vaccine; 9 7 Hepatitis A Vaccine; 10 8 Hepatitis B Vaccine; 11 9 Human Papillomavirus Vaccine; 12 10 Diphtheria Toxoid, Tetanus Toxoid, and Acellular PertussisContaining Vaccines; 13 11 Meningococcal Vaccine; 14 12 Injection-Related Adverse Events; 15 13 Concluding Comments; 16 Appendix A: Glossary; 17 Appendix B: List of Adverse Events; 18 Appendix C: Literature Search Strategy; 19 Appendix D: Causality Conclusion Tables; 20 Appendix E: References; 21 Appendix F: Committee Biosketches; 22 Appendix G: Meeting Agendas; 23 Index
£58.40
Elsevier - Health Sciences Division Pharmacology and Physiology for Anesthesia
Book SynopsisTrade Review"a reference for anesthesia trainees seeking a concise resource for foundational concepts in physiology and pharmacology framed by clinical practice." "In this edition of Pharmacology and Physiology for Anesthesia, Hemmings and Talmage have curated a comprehensive resource from which anesthesia trainees could gain specialty-specific knowledge. Experienced practitioners, particularly those involved in resident education, may find that the brevity and clinical focus of the text presents an attractive alternative to other reference books on the subject. I recommend this textbook as a reference for anesthesia trainees seeking a concise resource for foundational concepts in physiology and pharmacology framed by clinical practice." --Canadian Journal of AnesthesiaTable of ContentsPharmacology and Physiology for Anesthesia, 2nd ed. Section 1. Basic Principles of Pharmacology 1. Mechanisms of Drug Action 2. Pharmacokinetics and Pharmacodynamics for Intravenous Anesthetics 3. Pharmacokinetics and Pharmacodynamics of Inhaled Anesthetics 4. Drug Metabolism and Pharmacogenetics 5. Physiology and Pharmacology of Obesity, Prematurity, and Aging 6. Pharmacodynamic Drug Interactions 7. Adverse Drug Reactions Section 2. Nervous System 8. Central Nervous System Physiology: Neurophysiology 9. Central Nervous System Physiology: Cerebrovascular 10. Pharmacology of Intravenous Anesthetics 11. Pharmacology of Inhaled Anesthetics 12. Neuropharmacology 13. Autonomic Nervous System: Physiology 14. Autonomic Nervous System: Pharmacology 15. Thermoregulation 16. Physiology of Pain 17. Intravenous Opioid Agonists and Antagonists 18. Oral and Non-Intravenous Opioids 19. Non-Opioid Analgesics and Anti-Inflammatory Drugs 20. Local Anesthetics 21. Neuromuscular Physiology and Pharmacology 22. Neuromuscular Blockers and Reversal Drugs Section 3. Cardiovascular System 23. Cardiovascular Physiology: Cellular and Molecular Regulation 24. Cardiovascular Physiology: Integrative Function 25. Vasopressors and Inotropes 26. Antihypertensive Drugs and Vasodilators 27. Anti-arrhythmic Drugs 28. Cardiopulmonary Resuscitation Section 4. Pulmonary System 29. Pulmonary Physiology 30. Pulmonary Pharmacology Section 5. Gastrointestinal and Endocrine Systems 31. Liver and Gastrointestinal Physiology 32. Liver and Gastrointestinal Pharmacology 33. Nutritional and Metabolic Therapy 34. Pharmacology of Postoperative Nausea and Vomiting 35. Endocrine Physiology 36. Endocrine Pharmacology 37. Physiology and Pharmacology of Obstetric Anesthesia Section 6. Immunity and Infection 38. Chemotherapy, Immunosuppression, and Anesthesia 39. Infection, Antimicrobial Drugs and Anesthesia Section 7. Fluid, Electrolyte and Hematologic Homeostasis 40. Renal Physiology 41. Intravascular Volume: Regulation and Replacement Therapy 42. Electrolytes and Diuretics Section 8. Blood and Hemostasis 43. Blood and Coagulation 44. Transfusion and Coagulation Therapy 45. Antiplatelet and Anticoagulant Therapy
£999.99
Elsevier - Health Sciences Division Applied Pharmacology for the Dental Hygienist
Book SynopsisTable of ContentsPart I: General Principles 1. Information, Sources, Regulatory Agencies, Drug Legislation, and Prescription Writing 2. Drug Action and Handling 3. Adverse Reactions Part II: Drugs Used in Dentistry 4. Autonomic Drugs 5. Nonopioid (Nonnarcotic) Analgesics 6. Opioid (Narcotic) Analgesics and Antagonists 7. Antiinfective Agents 8. Antifungal and Antiviral Agents 9. Local Anesthetics 10. General Anesthetics 11. Antianxiety Agents Part III: Drugs That May Alter Dental Treatment 12. Drugs for the Treatment of Cardiovascular Diseases 13. Drugs for the Treatment of Gastrointestinal Disorders 14. Drugs for the Treatment of Seizure Disorders 15. Drugs for the Treatment of Central Nervous System Disorders 16. Adrenocorticosteroids 17. Drugs for the Treatment of Respiratory Disorders and Allergic Rhinitis 18. Drugs for the Treatment of Diabetes Mellitus 19. Drugs for the Treatment of Other Endocrine Disorders 20. Antineoplastic Drugs Part IV: Special Situations 21. Emergency Drugs 22. Pregnancy and Breast Feeding 23. Substance Use Disorders 24. Natural/Herbal Products and Dietary Supplements 25. Oral Conditions and Their Treatment 26. Hygiene-Related Oral Disorders Appendix A: Medical Acronyms Appendix B: Medical Terminology Appendix C: What if. Appendix D: Oral Manifestations: Xerostomia and Taste Changes Appendix E: Children's Dose Calculations Glossary Drug Index Index
£61.74
Elsevier Science Natural Products in VectorBorne Disease
Book SynopsisTable of Contents1. Vector borne diseases Natural product Manangement : Current and Future perspectives 2. Evidence-based review of natural products for the management Onchocerciasis 3. Plant-derived compounds as potential treatment for arboviruses 4. Natural products in the management of Onchocerciasis 5. Combating the vectors and management of vector - borne diseases with essential oil nanoemulsions 6. Natural product for management of babesiosis 7. Antimicrobial Peptides, Nanocarrier systems, and Databases: Therapeutic Platform against Leishmaniasis 8. Marine Organisms as Natural Drug Leads in Combating Vector-Borne Diseases 9. Plant and Marine-Derived Antimalarial Agents 10. Natural products in the management of Schistosomiasis 11. An update on Antileishmanial Agents from Natural Resources 12. Plants with anti-dengue properties: A systematic review 13. Natural Products in Japanese Encephalitis 14. Algae natural products for potential vector borne disease management 15. Natural products in the management of Trypanosomiasis 16. Role of Ayurveda in vector born disease management 17. Medically important vector borne disease control through seaweeds against the virus disease Chikungunya 18. "Nano-biomaterials as novel modules in the delivery of Artemisinin and its derivatives for effective management of malaria" 19. Scientific and ethnopharmacological evidence of Carica papaya for the effective management of vector-borne disease 20. Nanoemulsion as a promising carrier of plant-derived repellents for mosquito-borne malaria control: Nanotechnology aspects 21. Insect repellent plants: A recent update 22. Natural Products Employed in the Management of Malaria
£103.50
Elsevier Science A Pharmacology Primer
Book SynopsisTable of Contents1. What is Pharmacology? 2. How Different Tissues Process Drug Response 3. Drug–Receptor Theory 4. Pharmacological Assay Formats: Binding 5. Drug Targets and Drug-Target Molecules 6. Agonists: The Measurement of Affinity and Efficacy in Functional Assays 7. Orthosteric Drug Antagonism 8. Allosteric Modulation 9. The Optimal Design of Pharmacological Experiments 10. Pharmacokinetics 11. Safety Pharmacology 12. The Drug Discovery Process 13. Selected Pharmacological Methods
£103.50
CRC Press Chiral Ligands
Book SynopsisMany new drugs on the market are chiral compounds, that is, they can exist in two non-superimposable mirror-image forms. Asymmetric catalysis encompasses a large variety of processes for obtaining such compounds. The performance of the catalyst in those processes largely depends on the ligand that makes up the catalyst. This book describes the most relevant ligand libraries for some key processes, including an overview of the state of art and the key mechanistic aspects that favor a high catalytic performance.Key Features: The book presents historical content from the time of discovery for each family of ligands. Provides a description of the synthetic route and the ligand library's application in various catalytic asymmetric reactions Suitable as supplementary reading for courses targeting the design, synthesis and application of chiral catalysts, asymmetric catalysis and sustainable production Edited by a distinguished scientist in the
£56.99
CRC Press Agricultural Extension
Book SynopsisAdvances in knowledge and technology have revolutionized the process of drug development, making it possible to design drugs for a given target or disease. Building on the foundation laid by the previous three editions, Smith and Williamsâ Introduction to the Principles of Drug Design and Action, Fourth Edition includes the latest information on topics such as gene therapy, computer-aided design, and molecular techniques including proteomics. Using real-world examples that illustrate the principles of drug design, the author explores the discovery of lead compounds and their manipulation in the production of non-toxic, metabolically stable drug candidates that will interact with target receptors in a predicted fashion.See whatâs new in the Fourth Edition: Fully updates and expands the contents Coverage of agonists and antagonists of neuro-transmitters Information on the design of stable peptide-like drugs The human genome and its impact on drug discovery and development Advances in therapy and pharmacokinetics Adopting a from-the-bench-to-the-marketplace approach, the book provides a thorough grounding in rational drug design. It emphasizes principles and elucidates a framework for basic drug design into which current and, more importantly, future drugs will fit.Trade Review“This book consists of 17 chapters on a variety of topics related to drug design and action. … This book is intended as a possible text for undergraduate chemistry students interested in medicinal chemistry, or for graduate students as a means to learn the basics of medicinal chemistry. … classical approaches are described for drug design with the inclusion of the more recent context of the human genome project … In summary, some medicinal chemists in academia or the pharmaceutical industry may find this book instructive for certain classes of biomolecules or classical approaches to drug design. It should probably be included in most comprehensive library collections of medicinal chemistry texts and monographs.” — Bruce L. Currie, Department of Pharmaceutical Sciences, Loma Linda University, California, in Journal of Medicinal Chemistry, , Vol. 50, No. 1, 2007 “The fourth edition of this book includes the latest information on topics such as gene therapy, computer-aided design, and molecular techniques including proteomics. … real-world examples that illustrate the principles of drug design … New features of this edition include: coverage of agonists and antagonists of neurotransmitters; the design of stable peptide-like drugs; the human genome and its impact on drug discovery and development; advances in therapy and pharmacokinetics.” — In Anticancer Research, Vol. 26, 2006 Promo CopyTable of ContentsProcesses of Drug Handling by the Body. The Design of Drug Delivery Systems. Fundamental Pharmacokinetics. Intermolecular Forces and Molecular Modeling. Drug Chirality and its Pharmacological Consequences. Quantitative Structure–Activity Relationships (QSAR) in Drug Design. Prodrugs. From Program Sanction to Clinical Trials: A Partial View of the Quest for Arimidex, A Potent, Selective Inhibitor of Aromatase. Design of Enzyme Inhibitors as Drugs. Peptide Drug Design. Combinatorial Chemistry: A Tool for Drug Discovery. Recombinant DNA Technology: Monoclonal Antibodies. The Human Genome and its Impact on Drug Discovery and Therapy. The Chemotherapy of Cancer. Neurotransmitters, Agonists, and Antagonists. Design of Antibacterial, Antifungal, and Antiviral Agents. Pharmaceutical Applications of Bioinorganic Chemistry. Index.
£108.00
Elsevier Science Pharmaceutical Biotechnology in Drug Development
Book SynopsisTable of Contents1. Introduction to modern concepts in pharmaceutical biotechnology and drug development 2. Pharmacokinetic and pharmacodynamics of biotechnology products 3. Role of biotechnology in amino acids modification 4. Role of biotechnology in nucleic acid modification 5. Monoclonal antibodies: Development, characterization and therapeutic application 6. Development of nanoparticles: recent developments and future prospects 7. Production of biopharmaceuticals from genetically modified organisms 8. Metabolomics as bioanalytical approach for pharmaceutical biotechnology in drug development 9. New biological targets for drug discovery and development 10. Signaling pathways of membrane-spanning receptors for drug discovery and development
£121.50
John Wiley & Sons Inc Drugreceptor Thermodynamics Introduction and Applications Life Sciences
Book SynopsisDrug-Receptor Thermodynamics is the first book to provide in depth coverage of principles and applications of thermodynamic drug-receptor interactions. The book starts from familiar points, making thermodynamics accessible to anyone interested in how drugs work. The ideas presented cover general principles as well as laying the groundwork for new ways of examining drug action. * covers an area of increasing interest and relevance in the field of drug design and discovery * excellent explanation of why thermodynamics is at the heart of drug action * contributions from many of the worlds leading experts in the field Anyone interested in drug receptor interaction will find something of use in this book. It will be of particular relevance for pharmacologists, health science researchers and medicinal chemists.Table of ContentsContributors. Foreword (R. Tallarida). Preface. PRINCIPLES. Introduction: On the Relevance of Thermodynamics to Pharmacology (R. Raffa). Mathematical Models of the Drug--Receptor Interaction: Theory of Drug Action (R. Tallarida). Thermodynamic Concepts: Evolution and Applications (I. Klotz). A Brief History of Thermodynamics Terminology and Notation (R. Battino). General Thermodynamic Definitions and Equations (I. Haq, et al.). Thermodynamic Models of Drug--Receptor Interactions: A General Introduction (G. Klebe, et al.). Effector--Receptor Interactions: Origin and Development of Energetic Perspectives (I. Klotz). Measurement of Drug--Receptor Binding Constants (D. Winzor & W. Sawyer). Heat Capacity in Ligand--Receptor Interactions (V. Pliska) Early Applications of Thermodynamics to Drug--Receptor Interactions (R. Raffa). SPECIFIC APPLICATIONS. Thermodynamics of Adenosine (A1 and A2A) Receptor Interactions (P. Borea, et al.). Thermodynamics of Benzodiazepine Receptor Interactions (R. Raffa). Thermodynamics of Catecholamine Receptor Interactions (G. Weiland). Thermodynamics of Muscarinic Receptor Interactions (Y. Landry & J.-P. Gies). Thermodynamics of Nicotonic Receptor Interactions (H. Arias). Thermodynamics of Ionotropic GABA_A, Glycine and 5-HT_3-type Serotonin Receptor Interactions (G. Maksay). Thermodynamics of Opioid Receptor Interactions (R. Raffa). Thermodynamics of Serotonin Receptor Interactions (A. Dalpiaz, et al.). Thermodynamics and Structural Basis of Insulin Receptor Interactions with Phosphotyrosine Binding Domains (A. Farooq & M. Zhou). Thermodynamics of the Visual-pigment System (E. Ito & H. Suzuki). Thermodynamics of Protein Modules Involved in Tyrosine Kinase Signaling Pathways (J. Bradshaw, et al.). Thermodynamics of Antibody-Fc-receptor Interactions: IgE and FcRI, FCII (R. Ghirlando & H. Gould). Metal Ion Binding to the Conantokins: Inhibitors of Ion Channel Opening of the NMDA Receptor (M. Prorok & F. Castellino). METHODS/ADVANCED CONCEPTS. Direct Method for the Determination of Thermodynamic Quantities (R. O'Brien, et al.). Enthalpy--Entropy Compensation and Solvent Reorganization (E. Grunwald). Basics of Correlations: Relevance to Enthalpy--Entropy Compensation (R. Raffa & R. Tallarida). Thermodynamic Maps of Receptor--Ligand Pairs Reveal How Some Proteins Bind (C. Camacho, et al.). Thermodynamic Distributions of Heterogeneous Receptor Populations (M. José & J. José). Protein-Ligand Docking as an Energy Optimization Problem (M. Totrov & R. Abagyan). Prediction of Ligand--Receptor Binding Thermodynamics by Free Energy Force Field (FEFF) 3D-QSAR Analysis (J. Tokarski). Hydrophobic Mode-targeted, Algorithmically Designed Peptide Ligands as Modulators of Protein Thermodynamic Structure and Function (A. Mandell, et al.). Non-equilibrium Thermodynamics and Kinetics of the Multidrug Transporter (S. Caplan & R. Johnstone). Convergence of Recombinant Mutagenesis and Kinetics Interaction Analysis for Revealing Receptor Recognition Mechanisms and Designing Receptor Ligands (I. Chaiken, et al.). Index.
£432.86
University of California Press Dictionary of the Ben cao gang mu Volume 3
Book SynopsisTable of ContentsAcknowledgments I. Introduction 1. The Ben cao gang mu Project 2. The Two Conflicting Origins of Chinese Medicine and Pharmaceutics 3. Chinese Materia Medica Literature 4. The Sources Cited4.1. Materia Medica and Medical Texts4.3 Sources Beyond Materia Medica and Medical Literature5. The Dictionary Entries5.1. Bibliographical Entries:5.2. Biographical Entries: II. Persons and Literary Sources III. Appendices Appendix A Chinese Dynasties Appendix B Index of Substance Entry (SE) in Alphabetical Order Appendix C List of Entries of Names of Persons Appendix D List of Entries of Literary Sources
£100.00
Elsevier Health Sciences Essentials of Kumar and Clarks Clinical Medicine
Book SynopsisTrade ReviewFrom customer reviews of the previous edition: 2018 BMA Awards: Winner, Internal Medicine "This book is amazing helpful. It goes through every core condition you need and is simply written and to the point but has all the information that is needed. As a medical student this book has been great for my studies" "Great book, small enough to take on the wards, full of information on the go. I love it." "Excellent little companion book." "Good book. It has all the basics that student needs to revise, write assignments etc"Table of Contents1 Ethics and Communication 2 Infectious Diseases 3 Gastroenterology and Nutrition 4 Liver, Biliary Tract, and Pancreatic Disease 5 Haematological Disease 6 Malignant Disease 7 Rheumatology 8 Water, Electrolytes, and Acid-Base Balance 9 Renal Disease 10 Cardiovascular Disease 11 Respiratory Disease 12 Critical Care Medicine 13 Clinical Pharmacology and Toxicology 14 Endocrine Disease 15 Diabetes Mellitus and Other Disorders of Metabolism 16 The Special Senses 17 Neurology 18 Dermatology 19 Elderly Medicine and Frailty
£30.39